Atlas Trials

Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients

Clinical trial NCT05009030 · COMPLETED

Trial details

NCT number
NCT05009030
Sponsor
Fundación GECP
Status
COMPLETED
Study type
OBSERVATIONAL
Lung CancerCovid19
Start date
2021-05-06
Primary completion
2022-03-28
Enrollment
794

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.